Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
Sturgeon CM, Hoffman BR, Chan DW, Ch'ng SL, Hammond E, Hayes DF, Liotta LA, Petricoin EF, Schmitt M, Semmes OJ, Söletormos G, van der Merwe E, Diamandis EP; National Academy of Clinical Biochemistry. Sturgeon CM, et al. Among authors: petricoin ef. Clin Chem. 2008 Aug;54(8):e1-e10. doi: 10.1373/clinchem.2007.094144. Epub 2008 Jul 7. Clin Chem. 2008. PMID: 18606634 Free PMC article.
Cancer diagnosis using proteomic patterns.
Conrads TP, Zhou M, Petricoin EF 3rd, Liotta L, Veenstra TD. Conrads TP, et al. Among authors: petricoin ef 3rd. Expert Rev Mol Diagn. 2003 Jul;3(4):411-20. doi: 10.1586/14737159.3.4.411. Expert Rev Mol Diagn. 2003. PMID: 12877381 Review.
Cancer proteomics: many technologies, one goal.
Conrads TP, Hood BL, Petricoin EF 3rd, Liotta LA, Veenstra TD. Conrads TP, et al. Among authors: petricoin ef 3rd. Expert Rev Proteomics. 2005 Oct;2(5):693-703. doi: 10.1586/14789450.2.5.693. Expert Rev Proteomics. 2005. PMID: 16209649 Review.
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.
Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, Bussey KJ, Kim S, Lababidi S, Lee JK, Pittaluga S, Scudiero DA, Sausville EA, Munson PJ, Petricoin EF 3rd, Liotta LA, Hewitt SM, Raffeld M, Weinstein JN. Nishizuka S, et al. Among authors: petricoin ef 3rd. Cancer Res. 2003 Sep 1;63(17):5243-50. Cancer Res. 2003. PMID: 14500354
Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW. Srinivasan R, et al. Exp Hematol. 2006 Jun;34(6):796-801. doi: 10.1016/j.exphem.2006.02.013. Exp Hematol. 2006. PMID: 16728285 Free article.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
Sturgeon CM, Hoffman BR, Chan DW, Ch'ng SL, Hammond E, Hayes DF, Liotta LA, Petricoin EF, Schmitt M, Semmes OJ, Söletormos G, van der Merwe E, Diamandis EP; National Academy of Clinical Biochemistry. Sturgeon CM, et al. Among authors: petricoin ef. Clin Chem. 2008 Aug;54(8):e1-e10. doi: 10.1373/clinchem.2007.094144. Epub 2008 Jul 7. Clin Chem. 2008. PMID: 18606634 Free PMC article.
374 results